Open-label Phase 2 Trial of AMB-05X for Patients With ctDNA(+) Colorectal Cancer After Curative-intent Treatment
Latest Information Update: 08 Oct 2024
At a glance
- Drugs AMB 051 (Primary)
- Indications Adenocarcinoma; Colon cancer; Colorectal cancer; Rectal cancer
- Focus Adverse reactions
- 08 Oct 2024 New trial record